We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca, Regeneron Say Their COVID-19 Antibodies Treatments Still Work on Omicron
AstraZeneca, Regeneron Say Their COVID-19 Antibodies Treatments Still Work on Omicron
Regeneron and AstraZeneca both say their therapeutic antibody cocktails remain active against Omicron, but questions remain in light of a Chinese study concluding that the variant escapes 85 percent of tested antibodies.